Advertisement

Topics

VaxGen Inc. Company Profile

13:13 EDT 23rd March 2019 | BioPortfolio

VaxGen Inc. is a biopharmaceutical company focused on the development, manufacture and commercialization of biologic products for the prevention and treatment of human infectious disease. Founded in 1995, VaxGen’s business strategy emphasizes the development and commercialization of vaccine candidates for the prevention of potential bioterrorism threats, specifically anthrax and smallpox. Our longer-term strategy entails leveraging our expertise and infrastructure to expand our product portfolio beyond biodefense vaccines and into commercial biologic products.

On November 4, 2004 VaxGen announced the U.S. government award of an $877.5 million contract to supply 75 million doses of anthrax vaccine for civilian defense.

To date, we have in-licensed all of our product candidates at little or no expense to the company. Although we focus on biologic products for the treatment and prevention of human infectious diseases and have significant experience with vaccines and advanced biopharmaceutical manufacturing, we are not wedded to any particular platform technology. We believe this strategy allows us to move quickly and opportunistically to take advantage of promising new products that serve important medical needs.

Location

1000 Marina BoulevardSuite 200
Brisbane
California
94005
United States of America

Contact

Phone: (650) 624-1000
Fax: (650) 624-1001


News Articles [0 Results]

None

Drugs and Medications [0 Results]

None

PubMed Articles [0 Results]

None

Clinical Trials [1 Associated Clinical Trials listed on BioPortfolio]

A Phase II Clinical Trial to Evaluate the Immunogenicity and Reactogenicity of the Recombinant HIV-1 Envelope Vaccines SF-2 rgp120 (CHO) [Chiron Vaccines] in MF59 Adjuvant and MN rgp120/HIV-1 [VaxGen] in Alum Adjuvant in Healthy Adults

To evaluate the safety and immunogenicity of SF-2 rgp120 vaccine in MF59 versus MN rgp120 vaccine in alum in volunteers who are seronegative for HIV-1. AS PER AMENDMENT 07/02/97: To determ...

Companies [3 Associated Companies listed on BioPortfolio]

VaxGen Incorporated

VaxGen were formed to continue development of AIDSVAX in partnership with Genentech. In connection with our formation, Genentech licensed to us the technology necessary for completing development and ...

VaxGen Inc.

VaxGen Inc. is a biopharmaceutical company focused on the development, manufacture and commercialization of biologic products for the prevention and treatment of human infectious disease. Founded in 1...

VaxGen, Inc.

More Information about "VaxGen Inc." on BioPortfolio

We have published hundreds of VaxGen Inc. news stories on BioPortfolio along with dozens of VaxGen Inc. Clinical Trials and PubMed Articles about VaxGen Inc. for you to read. In addition to the medical data, news and clinical trials, BioPortfolio also has a large collection of VaxGen Inc. Companies in our database. You can also find out about relevant VaxGen Inc. Drugs and Medications on this site too.

Advertisement
Quick Search
Advertisement
Advertisement

 

Relevant Topic

Infectious-diseases
Antiretroviral Therapy Clostridium Difficile Ebola HIV & AIDS Infectious Diseases Influenza Malaria Measles Sepsis Swine Flu Tropical Medicine Tuberculosis Infectious diseases are caused by pathogenic...


Corporate Database Quicklinks



Searches Linking to this Company Record